查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609131

奈米生物技术市场：按产品、按应用分类 - 2025-2030 年全球预测

Nanobiotechnology Market by Product (Nano-Enabled Drugs, Nanodevices, Nanoparticles), Application (Agriculture, Cancer Treatment, Diagnostics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年奈米生物技术市场价值为34.9亿美元，预计到2024年将达到41.1亿美元，复合年增长率为16.04%，到2030年将达到99.1亿美元。

奈米生物技术是奈米技术和生物技术交叉领域的一个快速发展的领域，专注于在分子和原子层面上操纵和控制生物和非生物系统。范围涵盖各种应用，从药物传输和诊断工具到农业创新和环境修復。对奈米生物技术的需求源于其透过实现精确治疗、提高药物疗效以及为许多行业提供可扩展的解决方案来彻底改变医疗保健的潜力。它用于癌症治疗、再生医学、疾病诊断等医疗和製药领域。奈米生物技术的最终用途范围还包括农业部门和环境部门，前者有助于营养物和农药的智慧输送系统，后者透过奈米材料对抗污染。

主要市场统计
基准年[2023] 34.9亿美元
预计年份 [2024] 41.1亿美元
预测年份 [2030] 99.1亿美元
复合年增长率（%） 16.04%

奈米生物技术市场的成长受到多种因素的推动，包括奈米科学技术的进步、研发资金的增加以及需要创新治疗的慢性疾病盛行率的上升。此外，个人化医疗日益增长的需求进一步推动其发展。然而，市场扩张受到诸如高成本、道德问题以及与奈米材料相关的监管问题等挑战的限制。生物技术公司和研究机构有机会建立策略伙伴关係关係以加速创新。此外，进入对先进医疗保健解决方案的需求不断增长的新兴市场具有巨大潜力。

奈米医学和奈米诊断等领域的投资是可取的。奈米生物技术的最大潜力在于药物传输系统的创新和精确诊断工具的开发，这可以带来显着的业务成长。也就是说，公司必须仔细应对监管环境，以确保合规性并解决安全问题。这个充满活力的市场需要不断的创新和适应，成功的公司将保持在生物技术进步的最前沿，同时从合资企业和策略联盟中受益。专注于探索永续奈米材料也可以使公司在环保意识日益增强的情况下处于有利地位。

市场动态：揭示快速发展的奈米生物技术市场的关键市场洞察

供需的动态相互作用正在改变奈米生物技术市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 越来越多地使用奈米生物技术来改善医疗保健
    • 药物发现和开发流程的增加
    • 利用奈米技术实现永续生医材料开发
  • 市场限制因素
    • 与奈米生物技术相关的伦理和环境问题
  • 市场机会
    • 加强基因组学和蛋白​​质组学研究
    • 奈米生物技术在农业中的新用途
  • 市场挑战
    • 有关奈米技术产品的法规

波特五力：驾驭奈米生物技术市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解奈米生物技术市场的外部影响

外部宏观环境因素在塑造奈米生物技术市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解奈米生物技术市场的竞争格局

对奈米生物技术市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵奈米生物技术市场供应商的绩效评估

FPNV定位矩阵是评估奈米生物技术市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了奈米生物技术市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对奈米生物技术市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加奈米生物技术的使用以改善医疗保健实践
      • 增加药物发现和开发过程
      • 利用奈米技术开发永续生医材料
    • 抑制因素
      • 与奈米生物技术相关的伦理和环境问题
    • 机会
      • 基因组学和蛋白​​质组学研究的增加
      • 奈米生物技术在农业中的新用途
    • 任务
      • 有关奈米技术产品的法规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章奈米生物技术市场：副产品

  • 用奈米技术创造的药物
  • 奈米装置
  • 奈米粒子
  • 奈米科技工具

第七章奈米生物技术市场：依应用分类

  • 农业
  • 癌症治疗
  • 诊断
  • 药物输送
  • 环境监测
  • 再生医学
  • 治疗药物

第八章美洲奈米生物技术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区奈米生物技术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲奈米生物技术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Agilent Technologies, Inc.
  • Analog Devices, Inc.
  • ANSELL LTD.
  • Arkema SA
  • Bruker Corporation
  • DuPont de Nemours, Inc.
  • Eurofins Scientific SE
  • Evonik Industries AG
  • Honeywell International Inc.
  • Merck KGaA
  • Nanoscience Instruments, Inc.
  • Nanospan Inc.
  • Sioen Industries NV
  • Texas Instruments Incorporated
  • Thermo Fisher Scientific Inc.
Product Code: MRR-C002B1C99568

The Nanobiotechnology Market was valued at USD 3.49 billion in 2023, expected to reach USD 4.11 billion in 2024, and is projected to grow at a CAGR of 16.04%, to USD 9.91 billion by 2030.

Nanobiotechnology is a burgeoning field at the crossroads of nanotechnology and biotechnology, focusing on the manipulation and control of biological and non-biological systems at the molecular and atomic levels. Its scope encompasses various applications, from drug delivery systems and diagnostic tools to agricultural innovations and environmental remediation. The necessity for nanobiotechnology arises from its potential to revolutionize healthcare by enabling precise medical treatments, improving drug efficacy, and providing scalable solutions for numerous industries. In terms of application, it finds use in medical and pharmaceutical segments, targeting cancer therapy, regenerative medicine, and disease diagnostics. The end-use scope of nanobiotechnology also includes agriculture, where it contributes to smart delivery systems for nutrients and pesticides, and in environmental sectors, addressing pollution through nanomaterials.

KEY MARKET STATISTICS
Base Year [2023] USD 3.49 billion
Estimated Year [2024] USD 4.11 billion
Forecast Year [2030] USD 9.91 billion
CAGR (%) 16.04%

Market growth in nanobiotechnology is propelled by several factors, including advancements in nanoscale science and technology, increased R&D funding, and a rising prevalence of chronic diseases necessitating innovative treatments. Additionally, the growing demand for personalized medicine further fuels its development. However, market expansion is tempered by challenges such as high costs, ethical concerns, and regulatory issues associated with nanomaterials. Opportunities lie in forming strategic partnerships between biotech companies and research institutions to accelerate innovation. Furthermore, tapping into emerging markets, which exhibit a growing demand for advanced healthcare solutions, presents significant potential.

Investment in areas such as nanomedicine and nano-enabled diagnostics is advisable. Nanobiotechnology's greatest promise lies in its capacity to innovate drug delivery systems and develop precise diagnostic tools, which can translate into substantial business growth. Nevertheless, companies must navigate the regulatory landscape meticulously to ensure compliance and address safety concerns. This dynamic market demands continuous innovation and adaptation, with successful firms poised to spearhead advancements in biotechnology while simultaneously benefitting from collaborative ventures and strategic alliances. Emphasizing research into sustainable nanomaterials could also position companies advantageously amid increasing environmental consciousness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nanobiotechnology Market

The Nanobiotechnology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing the use of nanobiotechnology for improving healthcare practices
    • Rising drug discovery and development processes
    • Utilization of nanotechnology for development of sustainable biomaterials
  • Market Restraints
    • Ethical and environmental issues associated with nanobiotechnology
  • Market Opportunities
    • Increasing research in genomics and proteomics
    • Emerging use of nanobiotechnology in agriculture
  • Market Challenges
    • Regulations governing nanotechnology products

Porter's Five Forces: A Strategic Tool for Navigating the Nanobiotechnology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nanobiotechnology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nanobiotechnology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nanobiotechnology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nanobiotechnology Market

A detailed market share analysis in the Nanobiotechnology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nanobiotechnology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nanobiotechnology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nanobiotechnology Market

A strategic analysis of the Nanobiotechnology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nanobiotechnology Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Agilent Technologies, Inc., Analog Devices, Inc., ANSELL LTD., Arkema S.A., Bruker Corporation, DuPont de Nemours, Inc., Eurofins Scientific SE, Evonik Industries AG, Honeywell International Inc., Merck KGaA, Nanoscience Instruments, Inc., Nanospan Inc., Sioen Industries NV, Texas Instruments Incorporated, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nanobiotechnology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Nano-Enabled Drugs, Nanodevices, Nanoparticles, and Nanotechnology Tools.
  • Based on Application, market is studied across Agriculture, Cancer Treatment, Diagnostics, Drug Delivery, Environmental Monitoring, Regenerative Medicines, and Therapeutics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing the use of nanobiotechnology for improving healthcare practices
      • 5.1.1.2. Rising drug discovery and development processes
      • 5.1.1.3. Utilization of nanotechnology for development of sustainable biomaterials
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical and environmental issues associated with nanobiotechnology
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research in genomics and proteomics
      • 5.1.3.2. Emerging use of nanobiotechnology in agriculture
    • 5.1.4. Challenges
      • 5.1.4.1. Regulations governing nanotechnology products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nanobiotechnology Market, by Product

  • 6.1. Introduction
  • 6.2. Nano-Enabled Drugs
  • 6.3. Nanodevices
  • 6.4. Nanoparticles
  • 6.5. Nanotechnology Tools

7. Nanobiotechnology Market, by Application

  • 7.1. Introduction
  • 7.2. Agriculture
  • 7.3. Cancer Treatment
  • 7.4. Diagnostics
  • 7.5. Drug Delivery
  • 7.6. Environmental Monitoring
  • 7.7. Regenerative Medicines
  • 7.8. Therapeutics

8. Americas Nanobiotechnology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Nanobiotechnology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Nanobiotechnology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Agilent Technologies, Inc.
  • 3. Analog Devices, Inc.
  • 4. ANSELL LTD.
  • 5. Arkema S.A.
  • 6. Bruker Corporation
  • 7. DuPont de Nemours, Inc.
  • 8. Eurofins Scientific SE
  • 9. Evonik Industries AG
  • 10. Honeywell International Inc.
  • 11. Merck KGaA
  • 12. Nanoscience Instruments, Inc.
  • 13. Nanospan Inc.
  • 14. Sioen Industries NV
  • 15. Texas Instruments Incorporated
  • 16. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NANOBIOTECHNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. NANOBIOTECHNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NANOBIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NANOBIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NANOBIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NANOBIOTECHNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANO-ENABLED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANODEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY NANOTECHNOLOGY TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NANOBIOTECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES NANOBIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM NANOBIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM NANOBIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NANOBIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. NANOBIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023